BRISTOL-MYERS SQUIBB COMPANY

BMY · NEW YORK STOCK EXCHANGE INC.

Pharmaceutical Preparation Manufacturing · US

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

ESG Overview

Overall: BBB (High)

E: AS: BBG: BB

ESG grades from public dataset.

ESG data: Public Company ESG Ratings (CC BY-NC-SA 4.0)

Market Data

Price $56.72 -0.41 (-0.72%)

Market Cap$116.66B

P/E Ratio19.52

EPS$—

52W High$62.89

52W Low$42.52

Beta0.23

Data from Finnhub · Updated Jun 15, 2026